Eugia US LLC
David Anderson is an accomplished professional with extensive experience in sales and account management within the pharmaceutical and healthcare industries. Currently serving as Strategic Account Manager at Eugia US LLC since September 2023, David previously held the position of Director of 503B Sales for Hikma Pharmaceuticals, where David successfully launched a new sterile compounding business. David has a proven track record of driving growth and achieving significant milestones, as demonstrated during tenures at Leucadia Pharmaceuticals and Mylan, where leadership led to multiple awards and product approvals. David also developed meaningful relationships in the healthcare sector while generating impressive sales growth at CCS Medical. David holds a BSBA in Finance from Northern Arizona University and an MBA in Business Administration from the University of Phoenix.
This person is not in any offices
Eugia US LLC
Eugia is an independent specialty pharmaceutical company focused on delivering generic sterile injectables, oncology, hormones, and ophthalmic medicines. Our best-in-class, dedicated manufacturing and R&D capabilities are poised to meet today’s customer needs, and we are committed to providing our customers and partners with high-quality specialty medicines. Our name embodies who we aspire to be as a company – EU meaning “good” and hyGIA being the goddess of good health – together reflecting our focus on delivering products that are foundational to ensuring good health for millions of people around the world. For more information, visit EugiaUS.com